论文部分内容阅读
检测了在大剂量化疗 (ＨＤＴ)和骨髓移植 (ＢＭＴ)后的免疫重建情况。第 1组于ＨＤＴ、ＢＭＴ后 1年随访免疫重建。第 2组 ,检测口服活性免疫调节剂乌苯美司 (百士欣 ,ｂｅｓｔａｔｉｎ)在ＨＤＴ、ＢＭＴ后增强免疫重建活力的情况。对 35例霍奇金病和非霍奇金淋巴瘤于ＨＤＴ、
Immune reconstitution following high-dose chemotherapy (HDT) and bone marrow transplantation (BMT) was examined. Group 1 was followed up for 1 year after HDT and BMT. In the second group, the activity of orally active immunomodulator ubiquitin (bestatin) was tested in HDT and BMT to enhance the immune reconstitution activity. Of 35 Hodgkin’s disease and non-Hodgkin’s lymphoma in HDT,